Streetbeat News

Price Targets

HLVX

Stifel analyst Stephen Willey has maintained a Buy rating on HilleVax (NASDAQ:HLVX) but has reduced the price target from $35 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:26 pm

TPR

BMO Capital analyst Simeon Siegel has maintained a Market Perform rating on Tapestry (NYSE:TPR) but has reduced the price target from $43 to $39.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:19 pm

SPTN

BMO Capital analyst Kelly Bania has maintained a Market Perform rating on SpartanNash (NASDAQ:SPTN) but has reduced the price target from $23 to $22.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:17 pm

PLUG

BMO Capital analyst Ameet Thakkar has maintained a Market Perform rating on Plug Power (NASDAQ:PLUG) but has reduced the price target from $8 to $3.75.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:16 pm

NTLA

BMO Capital analyst Kostas Biliouris has maintained an Outperform rating on Intellia Therapeutics (NASDAQ:NTLA) but reduced the price target from $64 to $62.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:14 pm

NBIX

BMO Capital analyst Evan Seigerman has maintained a Market Perform rating on Neurocrine Biosciences (NASDAQ:NBIX) but has reduced the price target from $111 to $100.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:12 pm

IPI

BMO Capital analyst Joel Jackson has maintained a Market Perform rating on Intrepid Potash (NYSE:IPI) but has reduced the price target from $25 to $21.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:10 pm

WPM

BMO Capital analyst Jackie Przybylowski has maintained an Outperform rating on Wheaton Precious Metals (NYSE:WPM) but reduced the price target from $58 to $57.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:08 pm

IAG

BMO Capital analyst Jackie Przybylowski has maintained an Outperform rating on Iamgold (NYSE:IAG) but reduced the price target from $3.25 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:05 pm

BN

BMO Capital analyst Sohrab Movahedi has maintained an Outperform rating on Brookfield (NYSE:BN) but has reduced the price target from $45 to $42.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 8:03 pm